When was SentreHEART founded?

SentreHEART was founded in 2005.

Where is SentreHEART located?

SentreHEART is headquartered in Redwood City, United States.

Is SentreHEART a funded company?

SentreHEART is a funded company, having raised a total of $69M across 5 funding rounds to date. The company's 1st funding round was a $***** Series A round.

When was the latest funding round of SentreHEART?

SentreHEART's latest funding was a $***** Series D round on Oct 14, 2016, with participation from 5 investors. Its primary sector is Surgical Instruments. In United States, the Surgical Instruments sector has seen $185M in funding in 2026 to date.

Where does SentreHEART rank among its competitors?

SentreHEART ranks 4th amongst 35 active competitors, of which 12 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Planatome, which secured $5M in Oct, 2023.

Who are the top competitors of SentreHEART?

SentreHEART's top competitors include Ceterix, Tepha and Anchora Medical. Among them, Planatome secured the most recent funding round in October, 2023.

SentreHEART - 2026 Company Profile, Team, Funding & Competitors

Company Details

Innovating atrial fibrillation treatment and pain management solutions for healthcare professionals. They are dedicated to developing and delivering innovative medical devices and therapies for atrial fibrillation (Afib) and related conditions. Their offerings include surgical ablation systems, left atrial appendage management solutions, and cryo nerve block therapy for pain management. They provide healthcare professionals with a comprehensive suite of tools and resources, including education, training, and clinical evidence, to improve patient outcomes. They focus on minimally invasive surgical instruments and techniques, offering a range of products like ablation generators, dissection systems, and access devices. They are committed to advancing the treatment of Afib and post-operative pain through continuous innovation and collaboration with the medical community.

Key Metrics

Founded Year

2005

Location

Redwood City, United States

Stage

Acquired

Total Funding

$69M in 5 rounds

Latest Funding Round

Series D, Oct 14, 2016, $*****

Investors

Deerfield & 6 more

Ranked

4^th among 35 active competitors

Similar Companies

Ceterix & 38 more

Exit Details

Acquired by AtriCure (Aug 12, 2019)

View SentreHEART's full profile

SentreHEART got acquired by AtriCure on Aug 12, 2019.

Click here to take a look at SentreHEART's acquisition in detail

SentreHEART has raised a total funding of $69M over 5 rounds. Its latest funding round was a Series D round on Oct 14, 2016 for $*****. 5 investors participated in its latest round. SentreHEART has 7 institutional investors.

Here is the list of recent funding rounds of SentreHEART:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 14, 2016	4435463	Series D	4519634	7101777	5301125	9988534
Jun 04, 2012	4326388	Series C	7490470	6059081	2517338	USVP & 1 more
Jan 2007	5120747	Series B	9844276	3645967	7887752	4491419

Access funding benchmarks and valuations. Sign up today!

View details of SentreHEART's funding rounds and investors

The founders of SentreHEART is Russell Seiber.

Here are the details of SentreHEART's key team members:

Russell Seiber: President, CEO & Founder of SentreHEART.

View details of SentreHEART's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of SentreHEART include Ceterix, Tepha and Anchora Medical. Here is the list of Top 10 competitors of SentreHEART, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ceterix 2010, Menlo Park (United States), Acquired	Suture passer for orthopedic srugery	$73.9M	Versant Ventures, CRG & 7 others	52/100
2nd	Tepha 1998, Lexington (United States), Acquired	Global medical technology company advancing healthcare through innovative solutions and services	$39.7M	Rosetta Capital, The Vertical Group & 4 others	39/100
3rd	Anchora Medical 2014, Yokneam Illit (Israel), Series B	Micro laparoscopic device for single & continuous suturing	$4.5M	HOYA, Tal Ventures & 3 others	39/100
4th	SentreHEART 2005, Redwood City (United States), Acquired	Innovating atrial fibrillation treatment and pain management solutions for healthcare professionals	$69M	Deerfield, Decheng Capital & 5 others	38/100
5th	Gordian Surgical 2012, Misgav (Israel), Series A	A trocar with an integrated closure system	$7.25M	VI Ventures, Pirveli Ventures & 3 others	37/100
6th	Planatome 2017, Phoenix (United States), Series A	Developer of surgical scalpels for hospital & doctors use	$6M	-	35/100
7th	Mellon Medical 2013, Nijmegen (Netherlands), Series B	A suturing device with only one hand needed to operate the device	$7.09M	BioGeneration Ventures, Thuja Capital & 3 others	34/100
8th	Surgical Specialties 1999, Wyomissing (United States), Acquired	Developer of surgical knives and wound closure products	-	Aretex Capital Partners	33/100
9th	Suturion 2018, Lund (Sweden), Funding Raised	Developer of sewing machine for long surgical suture lines	-	Aktiebolaget Segulah, Almi Invest & 2 others	32/100
10th	EnVision Endoscopy 2018, Somerville (United States), Funding Raised	Developer of devices for gastrointestinal endoscopic surgery	-	MassChallenge, MedTech Innovator & 2 others	31/100